Evidence map›Paper›PMID 39038255›Full record

ArticleJCO clinical cancer informatics2024

Natural Language Processing Algorithm to Extract Multiple Myeloma Stage From Oncology Notes in the Veterans Affairs Healthcare System.

Sergey D Goryachev, Cenk Yildirim, Clark DuMontier, Jennifer La, Mayuri Dharne, J Michael Gaziano, Mary T Brophy, Nikhil C Munshi, Jane A Driver, Nhan V Do and 1 more

Abstract read
In one paragraph

Article in JCO clinical cancer informatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sergey D GoryachevMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Boston, MA.
Cenk YildirimMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Boston, MA.
Clark DuMontierNew England Geriatrics Research, Education and Clinical Center, VA Boston Healthcare System, Boston, MA.ORCID 0000-0003-2582-7816
Jennifer LaMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Boston, MA.ORCID 0000-0003-2266-0221
Mayuri DharneVA Boston Healthcare System, Boston, MA.
J Michael GazianoMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Boston, MA.
Mary T BrophyMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Boston, MA.ORCID 0000-0003-2314-4368
Nikhil C MunshiVA Boston Healthcare System, Boston, MA.ORCID 0000-0002-7344-9795
Jane A DriverNew England Geriatrics Research, Education and Clinical Center, VA Boston Healthcare System, Boston, MA.
Nhan V DoMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Boston, MA.ORCID 0000-0001-6868-7011
Nathanael R FillmoreMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Boston, MA.ORCID 0000-0002-8058-3423

Funding

Trageting the Multiple Myeloma EpigenomeP50CA100707 · NCI · DANA-FARBER CANCER INSTITUTE · PI ANDERSON, KENNETH C. · 2003 to 2023
$45.0M
Preparing For What Is Next With Aducanumab In Real World SettingsR33AG057806 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Christopher Barrett Bowling, Ana Roman Quinones · 2018 to 2026
$9.0M
MOLECULAR MANIPULATION TO ENHANCE ANTI-MYELOMA RESPONSEI01BX001584 · VA · VA BOSTON HEALTH CARE SYSTEM · PI MUNSHI, NIKHIL C. · 2013 to 2025
–
Integration of Geriatric Measures Alongside Disease-Based Measures to Advance Precision Oncology for Older Veterans with Multiple MyelomaIK2CX002218 · VA · VA BOSTON HEALTH CARE SYSTEM · PI DUMONTIER, CLARK WILLIAM · 2021 to 2024
–
BLRD VA I01 BX001584CSRD VA IK2 CX002218NCI NIH HHS P50 CA100707NIA NIH HHS R33 AG057806
6 · The paper itself

Abstract

purposeStage in multiple myeloma (MM) is an essential measure of disease risk, but its measurement in large databases is often lacking. We aimed to develop and validate a natural language processing (NLP) algorithm to extract oncologists' documentation of stage in the national Veterans Affairs (VA) Healthcare System.

methodsUsing nationwide electronic health record (EHR) and cancer registry data from the VA Corporate Data Warehouse, we developed and validated a rule-based NLP algorithm to extract oncologist-determined MM stage. To that end, a clinician annotated MM stage within over 5,000 short snippets of clinical notes, and annotated MM stage at MM treatment initiation for 200 patients. These were allocated into snippet- and patient-level development and validation sets. We developed MM stage extraction and roll-up algorithms within the development sets. After the algorithms were finalized, we validated them using standard measures in held-out validation sets.

resultsWe developed algorithms for three different MM staging systems that have been in widespread use (Revised International Staging System [R-ISS], International Staging System [ISS], and Durie-Salmon [DS]) and for stage reported without a clearly defined system. Precision and recall were uniformly high for MM stage at the snippet level, ranging from 0.92 to 0.99 for the different MM staging systems. Performance in identifying for MM stage at treatment initiation at the patient level was also excellent, with precision of 0.92, 0.96, 0.90, and 0.86 and recall of 0.99, 0.98, 0.94, and 0.92 for R-ISS, ISS, DS, and unclear stage, respectively.

conclusionOur MM stage extraction algorithm uses rule-based NLP and data aggregation to accurately measure MM stage documented in oncology notes and pathology reports in VA's national EHR system. It may be adapted to other systems where MM stage is recorded in clinical notes.

Indexed as

AlgorithmsElectronic Health RecordsMultiple MyelomaNatural Language ProcessingNeoplasm StagingUnited States Department of Veterans AffairsFemaleHumansMaleUnited StatesVeterans

Identifiers

PMID39038255
PMCPMC11371094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.